Literature DB >> 20888737

Costs of illness and care in Parkinson's disease: an evaluation in six countries.

Sonja von Campenhausen1, Yaroslav Winter, Antonio Rodrigues e Silva, Christina Sampaio, Evzen Ruzicka, Paolo Barone, Werner Poewe, Alla Guekht, Céu Mateus, Karl-P Pfeiffer, Karin Berger, Jana Skoupa, Kai Bötzel, Sabine Geiger-Gritsch, Uwe Siebert, Monika Balzer-Geldsetzer, Wolfgang H Oertel, Richard Dodel, Jens P Reese.   

Abstract

We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted in six countries. Economic data were collected over a 6-month period and presented from the societal perspective. The total mean costs per patient ranged from EUR 2620 to EUR 9820. Direct costs totalled about 60% to 70% and indirect costs about 30% to 40% of total costs. The proportions of costs components of PD vary notably; variations were due to differences in country-specific health system characteristics, macro economic conditions, as well as frequencies of resource use and price differences. However, inpatient care, long-term care and medication were identified as the major expenditures in the investigated countries.
Copyright © 2010 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20888737     DOI: 10.1016/j.euroneuro.2010.08.002

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  28 in total

Review 1.  Early versus delayed initiation of pharmacotherapy in Parkinson's disease.

Authors:  Matthias Löhle; Carl-Johan Ramberg; Heinz Reichmann; Anthony H V Schapira
Journal:  Drugs       Date:  2014-04       Impact factor: 9.546

2.  The direct costs of multiple sclerosis-study in the Czech Republic.

Authors:  Petra Maresova; Martin Valis; Michal Novotny; Zbyšek Pavelek; Kamil Kuca
Journal:  Neurol Sci       Date:  2018-09-03       Impact factor: 3.307

3.  Patient-centered integrated healthcare improves quality of life in Parkinson's disease patients: a randomized controlled trial.

Authors:  Carsten Eggers; R Dano; J Schill; G R Fink; M Hellmich; L Timmermann
Journal:  J Neurol       Date:  2018-02-01       Impact factor: 4.849

4.  Reversible Pharmacological Induction of Motor Symptoms in MPTP-Treated Mice at the Presymptomatic Stage of Parkinsonism: Potential Use for Early Diagnosis of Parkinson's Disease.

Authors:  Gulnara R Khakimova; Elena A Kozina; Valerian G Kucheryanu; Michael V Ugrumov
Journal:  Mol Neurobiol       Date:  2016-05-19       Impact factor: 5.590

5.  Co-occurring chronic conditions and healthcare expenditures associated with Parkinson's disease: a propensity score matched analysis.

Authors:  Sandipan Bhattacharjee; Usha Sambamoorthi
Journal:  Parkinsonism Relat Disord       Date:  2013-05-13       Impact factor: 4.891

Review 6.  Economic Evaluation of Interventions in Parkinson's Disease: A Systematic Literature Review.

Authors:  Nafsika Afentou; Johan Jarl; Ulf-G Gerdtham; Sanjib Saha
Journal:  Mov Disord Clin Pract       Date:  2019-04-11

7.  Factors Associated with Health-Related Quality of Life in Late-Stage Parkinson's Disease.

Authors:  Kristina Rosqvist; Per Odin; Stefan Lorenzl; Wassilios G Meissner; Bastiaan R Bloem; Joaquim J Ferreira; Richard Dodel; Anette Schrag
Journal:  Mov Disord Clin Pract       Date:  2021-03-23

8.  Cost-Effectiveness of Device-Aided Therapies in Parkinson's Disease: A Structured Review.

Authors:  Katarzyna Smilowska; Daniel J van Wamelen; Tomasz Pietrzykowski; Alexander Calvano; Carmen Rodriguez-Blazquez; Pablo Martinez-Martin; Per Odin; K Ray Chaudhuri
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

9.  Quality of life and costs in Parkinson's disease: a cross sectional study in Hungary.

Authors:  Gertrúd Tamás; László Gulácsi; Dániel Bereczki; Petra Baji; Annamária Takáts; Valentin Brodszky; Márta Péntek
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

10.  Health-related quality of life in Parkinson's disease patients in northeastern Sicily, Italy: (An ecological perspective).

Authors:  Letteria Spadaro; Lilla Bonanno; Giuseppe Di Lorenzo; Placido Bramanti; Silvia Marino
Journal:  Neural Regen Res       Date:  2013-06-15       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.